Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan
· Delayed Price · Currency is TWD 33.35
-0.20 (-0.60%)
At close: Dec 5, 2025
Easywell Biomedicals Revenue
Easywell Biomedicals had revenue of 174.43M TWD in the quarter ending September 30, 2025, a decrease of -8.42%. This brings the company's revenue in the last twelve months to 588.89M, up 21.72% year-over-year. In the year 2024, Easywell Biomedicals had annual revenue of 540.44M with 98.96% growth.
Revenue (ttm)
588.89M
Revenue Growth
+21.72%
P/S Ratio
7.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 540.44M | 268.81M | 98.96% |
| Dec 31, 2023 | 271.63M | 92.73M | 51.83% |
| Dec 31, 2022 | 178.90M | -18.38M | -9.32% |
| Dec 31, 2021 | 197.28M | -70.38M | -26.29% |
| Dec 31, 2020 | 267.65M | -92.31M | -25.64% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 34.99M |
| PharmaEssentia | 13.82B |
| Lotus Pharmaceutical | 18.66B |
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 42.59M |
| Center Laboratories | 1.57B |
| Pegavision | 6.90B |